English

This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.

This fact sheet provides information on latent tuberculosis infection (LTBI) for patients.

These guidelines aim to reduce morbidity and mortality related to TB and HIV-associated TB among people who inject drugs (PWID) through the integrated delivery of a comprehensive and holistic package of care. The guidelines provide an update of the 2008 Policy guidelines for collaborative TB and HIV services for injecting and other drug users: an integrated approach.

This quick reference tool provides suggestions for replacing stigmatizing language with non-hurtful words and phrases.

This pocket guide is intended to assist clinicians in managing patients with HIV and  LTBI, and drug-susceptible pulmonary TB disease. The guide includes signs and symptoms, adult dosing, dosage forms, drug-drug interactions, side effects, and patient counseling points.

This report details the steps that governments of countries with high burdens of TB-HIV and their partners have taken to turn a coordinated response to TB-HIV into reality at the country level, as well as the remaining gaps.

The purpose of this document is to provide guidance for clinicians, nurses, and hospital infection preventionists on the use of the Xpert MTB/RIF assay when making decisions to discontinue airborne infection isolation for persons with suspected, infectious pulmonary TB.

This video provides information on how to administer directly observe therapy (DOT).

This quick reference guide provides information on how to correctly administer and read a tuberculin skin test (TST).

This website contains resources, materials, and links to latent TB infection and U.S. Preventive Services Task Force (USPSTF) materials.